Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma

被引：25

作者：

Nikiforow, Sarah ^{[1
,2
]}

Werner, Lillian ^{[3
]}

Murad, Joana ^{[4
]}

Jacobs, Matthew ^{[5
]}

Johnston, Lauren ^{[5
]}

Patches, Sarah ^{[5
]}

White, Randie ^{[5
]}

Daley, Heather ^{[5
]}

Negre, Helene ^{[5
]}

Reder, Jake ^{[4
]}

Sentman, Charles ^{[6
]}

Wade, Terri ^{[4
]}

Schmucker, Adam ^{[4
]}

Lehmann, Frederic Francois ^{[7
]}

Snykers, Sarah ^{[7
]}

Allen, Rachel ^{[7
]}

Dipietro, Heidi ^{[1
]}

Cummings, Kristen ^{[1
]}

Galinsky, Ilene ^{[1
]}

Munshi, Nikhil C. ^{[1
,2
]}

Schlossman, Robert L. ^{[2
]}

Stone, Richard M. ^{[1
,2
]}

Neuberg, Donna S. ^{[3
]}

Soiffer, Robert J. ^{[1
,2
]}

Dranoff, Glenn ^{[1
,2
]}

Ritz, Jerome ^{[1
,2
]}

Baumeister, Susanne H. C. ^{[8
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[2] Harvard Med Sch, Boston, MA USA

[3] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA USA

[4] Celdara Med LLC, Lebanon, NH USA

[5] Dana Farber Canc Inst, Boston, MA USA

[6] Geisel Sch Med, Dartmouth, NS, Canada

[7] Celyad, Celyad, SA, Australia

[8] Boston Childrens Hosp, Boston, MA USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.4052.4052

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4052

引用

页数：5

共 50 条

[41] GPRC5D CART cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
Zhang, Mingming
Wei, Guoqing
Zhou, Linghui
Zhou, Jincai
Chen, Siye
Zhang, Wei
Wang, Dongrui
Luo, Xueping
Cui, Jiazhen
Huang, Simao
Fu, Shan
Zhou, Xinkai
Tang, Yu
Ding, Xiaomin
Kuang, Jiao
He, Xiaowen Peter
Hu, Yongxian
Huang, He
LANCET HAEMATOLOGY, 2023, 10 (02): : E107 - E116
[42] Natural Killer T Cells Expressing a GD2-CAR and IL-15 for Children with Neuroblastoma - A First-In-Human Phase 1 Trial
Heczey, Andras
Courtney, Amy
Robinson, Simon
Liu, Ka
Ghatwai, Nisha
Savoldo, Barbara
Dotti, Gianpietro
Metelitsa, Leonid
MOLECULAR THERAPY, 2020, 28 (04) : 555 - 555
[43] Initial data from a phase 1, first-in-human clinical trial for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy (TCR-T) for solid tumors.
Thomas, Sajeve Samuel
Pico, Brian
Henick, Brian S.
Leidner, Rom
Samhouri, Yazan
Isaacs, James
Weiss, Jared
Hurwitz, Michael E.
Grewal, Jaspreet Singh
Luke, Jason J.
Chattopadhyay, Shrikanta
Wang, Yun
Motta, Marlyane
Murray, Jim
Barton, Debora
Pinchasik, Dawn
MacBeath, Gavin
Moser, Justin C.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[44] Data from first-in-human study of EXS21546, an A2A receptor antagonist, now progressing into phase 1 in RCC/NSCLC
Diaz, Nieves
Garratt, Holly
Zemla-Brown, Aleksandra
Dominguez, Maria
Helmer, Eric
Alt, Isabella
Sehlke, Robert
Hieger, Norbert
Winkler-Penz, Thomas
Boudesco, Christophe
Vladimer, Gregory
Wilde, Tom
Evans, Philip
Italiano, Antoine
Krams, Michael
CANCER RESEARCH, 2023, 83 (08)
[45] Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human Study
Bumma, Naresh
Richter, Joshua
Brayer, Jason
Zonder, Jeffrey A.
Dhodapkar, Madhav
Shah, Mansi R.
Hoffman, James E.
Mawad, Raya
Maly, Joseph J.
Lentzsch, Suzanne
Suvannasankha, Attaya
Roy, Pourab
Dey, Jyotirmoy
Chokshi, Dhruti
Boyapati, Anita
Visich, Jenn
Houvras, Yariv
Lorenc, Karen Rodriguez
Kroog, Glenn S.
Jagannath, Sundar
BLOOD, 2022, 140 : 10140 - 10141
[46] A phase 1, first-in-human study of autologous monocytes engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2-overexpressing solid tumors.
Abdou, Yara
Pohlmann, Paula R.
Maziarz, Richard T.
Murthy, Hemant S.
Yuan, Yuan
Krishnamurthy, Anuradha
Reiss, Kim Anna
Isaacs, James
Blumenthal, Daniel
Gabitova, Linara
Menchel, Brett
Locke, Kenneth
Wetzel, Jeanette
Klichinsky, Michael
Cushing, Daniel
Condamine, Thomas
Sohal, Davendra
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[47] Phase I First-in-Human Study on the Feasibility, Safety, and Antitumor Activity of CD4-Redirected Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with CD4+T-Cell Malignancies (TCM)
Assi, Rita
Hagag, Nabil
Farag, Sherif
Emmons, Robert V. B.
Carter, Allie
Czader, Magdalena
Abonour, Rafat
Apetoh, Lionel
Ma, Yupo
Salman, Huda S.
BLOOD, 2023, 142
[48] Deep and Durable Remissions of Relapsed Multiple Myeloma on a First-in-Humans Clinical Trial of T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain
Mikkilineni, Lekha
Manasanch, Elisabet E.
Vanasse, Danielle
Brudno, Jennifer N.
Mann, Jennifer
Sherry, Richard
Goff, Stephanie L.
Yang, James C.
Lam, Norris
Maric, Irina
Stetler-Stevenson, Maryalice
Wang, Hao-Wei
Yuan, Constance M.
Stroncek, David F.
Highfill, Steven L.
Fellowes, Vicki
Ganadan, Micaela
Patel, Rashmika
Rosenberg, Steven A.
Kochenderfer, James N.
BLOOD, 2020, 136
[49] CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma
Madduri, Deepu
Berdeja, Jesus G.
Usmani, Saad Z.
Jakubowiak, Andrzej
Agha, Mounzer
Cohen, Adam D.
Stewart, A. Keith
Hari, Parameswaran
Htut, Myo
O'Donnell, Elizabeth
Munshi, Nikhil C.
Avigan, David E.
Deol, Abhinav
Lesokhin, Alexander M.
Singh, Indrajeet
Zudaire, Enrique
Yeh, Tzu-Min
Allred, Alicia J.
Olyslager, Yunsi
Banerjee, Arnob
Goldberg, Jenna D.
Schecter, Jordan M.
Jackson, Carolyn C.
Deraedt, William
Zhuang, Sen Hong
Infante, Jeffrey R.
Geng, Dong
Wu, Xiaoling
Carrasco, Marlene J.
Akram, Muhammad
Hossain, Farah
Rizvi, Syed
Fan, Frank
Jagannath, Sundar
Lin, Yi
Martin, Thomas, III
BLOOD, 2020, 136
[50] A phase 1, first-in-human (FIH) study of autologous macrophages engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants (pts) with HER2-overexpressing solid tumors
Abdou, Yara
Dees, Elizabeth Claire
Mortimer, Joanne E.
Pohlmann, Paula R.
Johnson, Melissa Lynne
Maziarz, Richard T.
Specht, Jennifer M.
Yuan, Yuan
Ueno, Naoto T.
Angelos, Mathew
Gill, Saar
Ronczka, Amy
Condamine, Thomas
Cushing, Daniel
Barton, Debora
Klichinsky, Michael
Swaby, Ramona F.
Reiss, Kim Anna
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

← 1 2 3 4 5 →